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DObjective:Our study describes the results from surgical slide tracheoplasty (STP) in children with long segment
tracheal stenosis.
Methods: Demographic and preoperative conditions, operative details, and outcome measures, including the
need for endoscopic airway intervention and mortality, were collected for children undergoing STP between
February 1995 and December 2012.
Results: One hundred one patients (median age, 5.8 months; range, 5 days-15 years) underwent STP.
Seventy-two patients (71.3%) had associated cardiovascular anomalies. Preoperative ventilation was necessary
in 56 patients (55.4%), whereas extracorporeal membrane oxygenation was required in 10 patients (9.9%).
Abnormal bronchial arborization was present in 39 children (38.6%), which included 13 patients (12.8%)
with an anomalous right upper lobe bronchus and 17 patients (16.8%) with tracheal trifurcation. Airway stenosis
extended into 1 or both bronchi in 24 patients (23.7%) and preoperative malacia was present in 24 patients
(23.7%). STP was extended into the bronchus in 47 patients (46.5%). Overall survival was 88.2% (mortality
in 12 patients). Post-STP balloon dilation was necessary in 45 patients (44.6%) and stenting was required in
22 patients (21.8%). Multivariate analysis revealed preoperative extracorporeal membrane oxygenation
(P<.05), preoperative malacia (P<.001), and bronchial stenosis (P<.05) to be adverse predictors of survival.
Preoperative malacia was a significant risk factor for stenting (P<.05).
Conclusions: STP is a versatile and reliable technique associated with low morbidity and mortality
when compared with previous strategies for children with long segment tracheal stenosis. The presence
of preoperative bronchomalacia is a significant risk factor for death and postoperative stenting. (J Thorac
Cardiovasc Surg 2014;147:1783-90)Long segment congenital tracheal stenosis (LSCTS) is a
severe and often life-threatening anatomical anomaly
constricting the trachea for>50% of its length. Whereas a
defining feature is the presence of complete tracheal rings,
many patients have other congenital anomalies. Cardiovas-
cular malformations such as pulmonary artery sling and ven-
tricular septal defects are common; however, both pulmonary
and gastrointestinal defectsmay also be present, highlighting
the heterogeneity found in these groups of children.1,2
Historically, LSCTS has often been associated with
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The Journal of Thoracic and Carapproaches advocated.3-8 These have included simple
resection, augmentation with cartilage or pericardial patch
graft, replacement with homograft, or slide tracheoplasty
(STP).9,10 Following initial reports from centers where
STP was shown to have a favorable outcome, we became
early adopters of this technique.7,11-13 Despite its
increasing use, most reported studies have been small and
long-term outcomes are rarely reported.
As the nationally funded quaternary referral unit for
complex pediatric airway disease, our unit receives nearly
all new cases of LSCTS in the United Kingdom. Our
approach to management involves a dedicated multi-
disciplinary team,13 and we now have gained>17 years
of experience in managing a diverse group of children
with very complex tracheal disease. This study reviews
our results and endeavors to determine predictors of adverse
outcome for children with LSCTS undergoing STP.
MATERIALS AND METHODS
Our study was a retrospective, consecutive case series of children
undergoing STP for LSCTS at Great Ormond Street Hospital for Children,
London, between February 1995 and December 2012. Institutional review
board approval was granted for this study. Data were recorded in a
registered database and subsequently analyzed for demographic and
specific pre- and perioperative characteristics. These included the presence
of cardiac and noncardiac anomalies, minimal tracheal diameter, airwaydiovascular Surgery c Volume 147, Number 6 1783
Abbreviations and Acronyms
CPB ¼ cardiopulmonary bypass
ECMO ¼ extracorporeal membrane oxygenation
ICU ¼ intensive care unit
LSCTS ¼ long segment congenital tracheal stenosis
OCT ¼ optical coherence tomography
STP ¼ slide tracheoplasty
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Darborization patterns, extent of tracheal stenosis, presence of bronchial
stenosis, the need for mechanical ventilation before surgery, and the need
for either pre- or postoperative extracorporeal membrane oxygenation
(ECMO). Preoperative bronchomalacia was defined as dynamic collapse
of the main bronchus by>50% (by diameter) on biplane bronchography.
Postoperative airway malacia was defined as dynamic collapse of
the airway (either tracheal or bronchial) of >50% diameter on
biplane bronchography. Operative details and postoperative management,
including complications and length of intensive care unit (ICU) stay
and postoperative ventilation were recorded. The need for airway
reintervention was defined as 3 endoscopic dilations.
Tracheobronchial arborization patterns and extent of stenoses were
defined as previously described.14 Arborization patterns were normal
bifurcation, anomalous right upper lobe or porcine bronchus (bronchus
suis), bronchial trifurcation, and single lung. Congenital bronchial stenosis
was defined as the presence of complete tracheal rings in at least 1 bronchus
(beyond carina or into a right upper lobe bronchus), with >50%
narrowing.14 Follow-up data, including the need for endoscopic
interventional radiology procedures (eg, tracheal and/or bronchial dilation
and/or stenting), were also collected.
Patient Management
All children referred to Great Ormond Street Hospital with LSCTS
are channeled through a dedicated multidisciplinary tracheal team.
Management follows a defined protocol and includes the following
mandatory investigations: bronchoscopy and bronchography, echocardio-
graphy, and thoracic imaging with computed tomography and/or magnetic
resonance imaging. Other investigations include lung volume-flow loops,
optical coherence tomography (OCT), and cardiac catheterization when
required.
STP is performed as previously described.1 Briefly, the surgery is
performed through a median sternotomy with cardiopulmonary bypass
(CPB). Where necessary, congenital cardiovascular anomalies are
corrected at the same time. Before commencing CPB, the anterior trachea
is exposed and the entire length of stenosis identified by external
inspection, or by needling the airway and identifying limits of the stenosis
with flexible bronchoscopy. The trachea is completely mobilized to just
beyond the limits of the complete rings, or until normal trachea and/or
bronchi are seen. Further mobilization may occasionally be required, and
can be achieved by releasing either Hilar lymph nodes below the carina
or the posterior pericardial reflection inferiorly. Superior mobilization is
routinely via division of the thyroid isthmus or very rarely by a hyoid
release. If no cardiovascular repairs are required, normothermic CPB is
established and the mobilized trachea divided at the midpoint of the
stenosis. Longitudinal incisions are made on opposite sides of proximal
(posteriorly) and distal (anteriorly) segments and the ends are spatulated.
An oblique sliding anastomosis is performed with interrupted mattress
polydioxanone (PDS) sutures. If a tracheostomy is present, and the stoma
is adjacent to the stenosis we advocate it be incorporated into the repair,
otherwise it is left for conventional de-cannulation once the patient needs
only minimal ventilation. Assessment of the effectiveness of repair is
judged by immediate postprocedural bronchoscopy and a leak test with1784 The Journal of Thoracic and Cardiovascular Surgradual insufflation of the lungs with the repair submerged in warm saline.
A mediastinal catheter is left in situ together with chest drains as required.
Mediastinal irrigation with 1% povidone-iodine solution (reconstituted
from 10% aqueous povidone iodine) in 0.9% saline is commenced at 2
mL/kg/h for 48 hours. Reservoir bags are changed every 24 hours and
before catheter withdrawal samples are tested for microbial colonization
(mediastinal contamination is assumed).
Postoperative management includes bedside fiberoptic bronchoscopy
at 24 hours to plan extubation. Further evaluation of the airway is
performed at 1 week with bronchoscopy and bronchography. Subsequent
evaluations (with or without balloon dilations) are performed according to
clinical need. Stent placement is only indicated in cases in which severe
postoperative malacia prevents withdrawal of ventilatory support or in
patients who fail to progress on noninvasive ventilation.1,13 In these
children, a made-to-order biodegradable PDS stent (Ella-CS, Hradec
Kralove, Czech Republic) is sometimes considered, because it resorbs over
an 8- to 12-week period.15 Other stents previously inserted were
balloon-expandable metal stents (Palmaz; Cordis, Warren, NJ), and
self-expanding nitinol stents (Niti-S; Pyramed, Escher, UK).
Bronchoscopy and bronchography delineate the full anatomical
configuration of the airway and provide dynamic information not easily
achievable with other forms of imaging. As previously described, these
procedures are performed simultaneously in an interventional radiology
suite.16 The child is anesthetized with either a laryngeal mask airway or
intubated, and without paralysis where possible. If intubated, the
endotracheal tube is withdrawn so that the upper trachea may be examined.
Small volumes (<1 mL) of iohexol (Omnipaque 240 mg/mL; Nycomed
Inc, Asker, Norway) are injected either via a catheter introduced through
the endotracheal tube or through the working channel of the bronchoscope
into the proximal trachea. Dynamic images are acquired in both
posteroanterior and lateral projections. OCT is performed in select patients
to clarify the status of airway cartilage formation. OCT is specifically used
to determine if cartilage rings are complete, fragmented, or absent.
Patients undergo OCT at the time of bronchoscopy and/or bronchography.
A floppy-tipped 0.36-mm diameter OCT wire (ImageWire 200; St Jude
Medical, St Paul, Minn) is passed through the side arm of the bronchoscope
or the bronchographic catheter and advanced to the region of interest.
Confirmation of positioning is obtained by direct visualization and/or
bronchography.17,18 If balloon dilation is required; for example, for
recurrent granulation tissue, an angioplasty catheter is selected (with a
balloon approximately the same size as the normal airway) and inflated
under fluoroscopic guidance until the stenosis is obliterated. Intervals
between ballooning are determined by clinical symptoms and the
appearance of the airway at bronchoscopy.
Data Analysis
Patient demographics and the nature of treatments were obtained from
hospital records. Data are presented as mean values  standard deviation,
medians and ranges, and/or binomial percentages, where appropriate.
Kaplan-Meier survival curves were plotted for outcome measures and
log-rank tests were performed to analyze differences between specific
subgroups. Risk factors for mortality and stent insertion were analyzed
with a Cox proportional-hazards regression model with the forward
(likelihood ratio) method applied. Data were analyzed and displayed
with SPSS software version 21.0 (IBM-SPSS, Inc, Armonk, NY) and Prism
6.0 (GraphPad Software Inc, La Jolla, Calif).RESULTS
One hundred one children (median age, 5.8months; range,
5 days-15 years) underwent STP. Patient demographics and
general characteristics are shown in Table 1. All children
had stenosis>50% of the length of the trachea and 89%gery c June 2014
TABLE 2. Associated cardiovascular anomalies
Cardiovascular anomaly n
Ventricular septal defect 15
Atrium septal defect 7
Atrioventricular septal defect 2
Left pulmonary artery sling 48
Tetralogy of Fallot 10
Vascular ring 4
Subaortic stenosis 3
Truncus arteriosus 2
Hypoplastic aortic arch 2
Persistent ductus arteriosus 4
Right aortic arch 2
Other* 5
*Consisting of double outlet right ventricle (n ¼ 1), anomalous left subclavian artery
(n ¼ 1), absent left pulmonary artery (n ¼ 1), aortopulmonary window (n ¼ 1), and
right pulmonary artery hypoplasia (n ¼ 1).
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Dhad>80% involvement. Twenty-four patients (24%) had a
stenosis extending into the main bronchi. In 47 children
(47%), the STP was extended into the bronchus. Seventy-
two patients (71%) had additional cardiac or great vessel
anomalies, 48 of whom (48%) had a left pulmonary artery
sling (Table 2). Cardiovascular anomalies were corrected
during the same procedure. CPB was used in all cases and
median time was 86 minutes (range, 38-323 minutes). Three
patients (3%) had tracheotomies inserted by other units
before referral. All 3 were decannulated at a later stage
when ventilatory requirements were minimal. Surgery was
not offered on 1 child with LSCTS due to the presence of
severe congenital anomalies, including intractable severe
bronchomalacia. During the period covered by our study,
9 children presented to our team with asymptomatic
LSCTS and at the time the study was completed the patients
were under surveillance without intervention. These patients
are not included in our analysis.
A wide variety of airway arborization patterns14 were
present in our cohort. Sixty-two patients (61%) presented
with normal tracheal bifurcation; 13 patients (13%) with
an anomalous right upper lobe bronchus; 17 patients
(17%) with tracheal trifurcation, and 9 patients (9%)
with a single lung. Forty-three children (43%) children
had concomitant congenital malformations. These included
VACTERL/VATER association in 6 patients (6%),
anorectal malformations in 7 patients (7%), and trisomy
21 in 8 patients (8%). Preoperatively, 10 patients (10%)
required ECMO, whereas 56 patients (55%) were
mechanically ventilated. Only 35 children (35%) were
stable and self-ventilating in air before surgery.
Twenty-four patients (24%) had preoperative malacia as
determined by bronchography. Median postoperative
ventilation time was 11 days (range, 0-755 days) and the
median ICU stay was 20 days (range, 2-477 days).TABLE 1. General characteristics and demographic data
Characteristic Result
Age 5.8 mo (5 d-15 y)
Sex, male:female 62:39
Weight, kg 5.9 (1.9-38.3)
Trachea minimum diameter, mm 2.2 (1-4)
Preoperative ventilation 56 (55)
Preoperative bronchomalacia 24 (24)
Preoperative ECMO 10 (10)
Congenital bronchial stenosis 24 (24)
Abnormal arborization* 39 (39)
Cardiovascular association 72 (71)
Congenital malformations 43 (43)
Postoperative ventilation, d 11 (0-755)
Endoscopic reintervention post-STP 48 (48)
Postoperative airway malacia 20 (20)
Values are presented as median (range) or n (%). ECMO, Extracorporeal membrane
oxygenation; STP, slide tracheoplasty. *Consisting of porcine bronchus, tracheal
trifurcation, and single lung.
The Journal of Thoracic and CarPostoperative airway malacia (tracheal or bronchial)
was present in 20 patients (20%), but was not shown
to be associated with either length of ICU stay (P ¼ .11)
or duration of postoperative ventilation (P ¼ .07).
Forty-eight children (48%) required post-STP endoscopic
intervention of the airway (balloon dilation and/or stenting)
and 45 children (45%) required balloon dilation (median 4,
range 1-27 times). Of those who underwent endoscopic
ballooning, 33 children required 3 dilations in a
postoperative period of 4 months. Thirty-seven tracheal
and/or bronchial stents were inserted into 22 patients
(22%) with 1 patient requiring 4 stents and another 7 stents
(stent-in-stent). Stent insertion in the first decade was
required in 29% (8 out of 29) of patients compared with
19% (14 out of 72) in the remainder of the study period.
A variety of stents were used over this period, including
29 (21%) balloon-expandable steel stents (Palmaz; Cordis),
and 2 (2%) Nitinol self-expandable stents (Niti-S;
Pyramed). During the past 4 years there has been increasing
trend to use bioabsorbable PDS stents (Ella-CS) which
account for 85% of stents (6 out of 7) during this period.
No tracheostomies were inserted during the study period.
Follow-up information was available for all patients for a
median duration of 4.6 years (range, 2.7 months-17 years).
In total there were 12 deaths (12%) of which 6 (6%) were
early and 6 (6%) were late. Four deaths were airway
related, 4 cardiac related, and 4 due to other causes. To
date there have been 5 deaths in the final 70 consecutive
patients. Analysis comparing outcome measures between
first and last quadrennial periods showed a significant
difference in postoperative ventilation time with the median
reducing from 67.5 days (range, 7-755 days) to 8.5 days
(range, 1-109 days). (Figure 1).
Complications included 3 patients (3%) with anasto-
motic dehiscence, of which 2 cases (2%) were secondary
to postoperative mediastinitis and required redo surgery
(these occurred during a period when continuous suturediovascular Surgery c Volume 147, Number 6 1785
FIGURE 1. A, Acquired experience improves outcomes as demonstrated by reduction of postoperative ventilation days in serial quadrennial periods
(P<.05). Postoperative ventilation days are expressed as median and interquartile ranges. B, Actuarial survival demonstrating significant improvement
in the second decade compared with the first (P<.05). *Implementation of tracheal multidisciplinary team.
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residual stenosis at 3 months and 8 (8%) had residual
stenosis at 9 months. Six children (6%) had persistent
pneumothoraces requiring re-intervention, 4 children
(4%) had a chylothorax, 2 children (2%) had pulmonary
hypertension, and 4 children (4%) had pneumopericardium
or pneumomediastinum. Four children (4%) had a phrenic
nerve injury and 3 children (3%) had a recurrent laryngeal
nerve injury that spontaneously resolved within 6 months.
Variables included in multivariate analysis were age,
sex, weight, minimal tracheal diameter, preoperative
invasive ventilation, preoperative bronchomalacia, con-
genital bronchial stenosis, abnormal arborization of the
airway, single lung, cardiovascular anomalies, other
congenital anomalies, CPB time, postoperative malacia,
and STP extending into the bronchus. Outcome measures
for multivariate analysis were overall survival and freedom
from stenting. Multivariate analysis revealed preoperative
ECMO (P<.05), congenital bronchial stenosis (P<.05),
and preoperative bronchomalacia (P < .001) were
predictors of mortality (Figure 2). Other variables were
not significant for survival (Table 3). Multivariate analysis
revealed preoperative malacia to be the only significant
predictive indicator for stenting (P<.05) (Figure 3).
DISCUSSION
LSCTS typically has been associated with significant
morbidity and mortality, with numerous reconstruction
techniques advocated for repair of the airway. Since first
being described in 1989 by Tsang and colleagues,19 STP
has been adopted increasingly as the preferred surgical
option for children with LSCTS, after early case
series highlighted its efficacy.10,11 Its ease of application to
a wide spectrum of stenotic airway disease has coined the
phrase, ‘‘1 slide fits all,’’7 with its use not only limited to
children with LSCTS but also extended to those with short
segment stenosis and proximal tracheal disease.20-22
Although surgery in these children can be challenging
due to their heterogeneous presentation, we have found1786 The Journal of Thoracic and Cardiovascular Surthe slide technique to be applicable to all airway
morphologies with low morbidity and mortality. Previous
studies have reported favorable outcomes for STP with
mortality reported at 5% to 30%.4,7,10,23 However, these
have been limited by either small cohort size and/or
limited length of follow-up. The largest case series to date
reported excellent outcomes with 5% mortality in 80
children undergoing STP, but with a median follow-up of
only 12 months.7 Our mortality rate is higher, at 10%, but
this may reflect our initial learning curve, longer follow-
up, and perhaps a more complex case mix. Certainly a
greater proportion of our patients required preoperative
ventilation and ECMO, and almost 25% had either
congenital bronchial stenosis and/or bronchomalacia.
Notably, such findings were either absent or unreported in
the Cincinnati experience,7 suggesting genuine cohort
differences between centers. Whereas this may simply
reflect the heterogeneity of LSCTS, it could also be a result
of differing referral pathways preselecting different patient
cohorts. At Great Ormond Street Hospital for Children we
see an unfiltered national population of patients, rather
than a specifically referred population.
During the past 2 decades, our approach to managing
children with LSCTS has naturally evolved, resulting in
improvements in hospital stay, postoperative ventilation
time, and survival. A significant learning curve was present
in the first quadrennial period that dramatically improved
with acquired experience, such that the final consecutive
70 patients had a mortality rate of 7%. Although the
application of STP in itself undoubtedly is a significant
contributor to improved outcomes, we believe that the
introduction of a multidisciplinary team has been central
to sustained improvements.13
Complications have been far from trivial, but we have
found a general improvement with increasing experience.
Granulation tissue is a common complication of airway
surgery, but we have observed that this is readily treated
with serial balloon dilation and we adopted a proactive
strategy toward treating this. With active surveillancegery c June 2014
FIGURE 2. A, Actuarial survival in children with and without congenital bronchial stenosis (complete tracheal rings extending into the a main bronchus)
(P< .05). B, Survival for children with and without preoperative bronchomalacia (P< .01). CTS, Congenital tracheal stenosis; CTBS, congenital
tracheobronchial stenosis.
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before it becomes problematic. This might explain our
higher intervention rates following surgery. Secondary
(ie, acquired) stenosis is quite rare and the vast majority
of patients (82%) are intervention free within a year after
surgery.
Predictors of adverse outcomes from our cohort have
been identified as preoperative ECMO, preoperative
bronchomalacia, and bronchial stenosis. It is unsurprising
that the need for preoperative ECMO is an adverse predictor
because it identifies a more challenging group. Typically,
ECMO has been reserved for the ‘‘can’t ventilate’’ scenario,
and is likely to represent a cohort of more severe distal
airway pathology. It is interesting to note the most adverse
predictor in our cohort was preoperative distal malacia
(P<.001) where the hazard ratio was 8. This can be quite
problematic to treat because the STP does not always
address this problem. In fact, a considerable amount ofTABLE 3. Multivariable regression* results with death or stenting as
outcome variable
Characteristic
Death Stenting
Hazard
ratio
P
value
Hazard
ratio
P
value
Age NS NS
Sex NS NS
Weight NS NS
Minimum tracheal diameter NS NS
Preoperative ventilation NS NS
Bronchial stenosis 4.7 <.05 NS
Preoperative malacia 8.4 <.001 3.0 <.05
Preoperative ECMO 5.4 <.05 NS
Cardiovascular association NS NS
Congenital malformation NS NS
CPB time NS NS
Postoperative malacia NS NS
Abnormal airway arborization NS NS
Single lung NS NS
Slide tracheoplasty into bronchus NS NS
Boldface indicates significant variables. NS, Not significant; ECMO, extracorporeal
membrane oxygenation; CPB, cardiopulmonary bypass. *Cox regression model (for-
ward [likelihood ratio] method applied).
The Journal of Thoracic and Carpreoperative malacia may be masked due to inherent
positive end-expiratory pressure generated by the stenosis.
In our experience, distal malacia may only become
clinically apparent when the stenosis is repaired by surgery.
Because a notable proportion of our cohort was identified
with preoperative malacia, it was presumed that longer
postoperative ventilation and ICU stays may be a due to
this phenomenon. Although our analysis did not reveal
this to be a specific predictor it did trend toward significance
(P¼ .07). We believe this to be an important factor to define
in the preoperative workup and we currently rely on
bronchography to evaluate preoperative bronchomalacia.
Our early experience with OCT assessment of the distal
airway suggests that it is a very complimentary tool for
evaluating the poor quality bronchial cartilage sometimes
seen in children with LSCTS.
Stenting is sometimes considered for patients with severe
recurrent stenosis (when serial balloon dilation fails and
reoperation is not feasible) and/or malacia. Although the
decision to stent is not taken lightly, it is sometimes
unavoidable. The only factor that was a significant predictor
of the need for stenting was preoperative bronchomalacia.
Our own early experience with balloon expandable metal
stents (Palmaz; Cordis) was not without complications.
Stents readily colonize, promote excessive secretions, and
are prone to secondary stenosis.24 As a result, we try to
avoid stenting wherever possible. Despite this, we would
in general prefer to insert 1 stents than to perform
tracheostomy following STP, especially now that
bioabsorbable stents are available.15 Because postoperative
airway malacia in most patients tend to resolve given
enough time, noninvasive ventilation with continuous
positive airway pressure is sometimes considered to
ameliorate the situation while the airway stiffens.
Similar to others, we have found STP to be an extremely
versatile technique that can be applied in patients with a
variety of tracheobronchial arborization patterns.25,26 The
ability to extend the slide is not only beneficial for
bronchial stenosis but also for arborization patterns where
there is a limited amount of trachea between the carina
and an anomalous right upper lobe bronchus (porcinediovascular Surgery c Volume 147, Number 6 1787
FIGURE 3. A, Kaplan-Meier plots demonstrating freedom from stenting for children with and without preoperative bronchomalacia (P < .05).
B, Preoperative malacia. *Bronchography shows>50% diameter collapse in expiration in the left main bronchus.
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incision into the bronchus is often met with some
reservation, but it is noteworthy that the multivariate
analysis did not reveal this to be a predictor of adverse
outcome, suggesting the act of entering the bronchus,
in itself, is not a risk factor. Instead, multivariate analysis
showed bronchial stenosis itself to be more of a predictor
of mortality. It is unclear what degree of stenosis would
benefit from extending the slide repair, and it is possible
that only the most stenotic bronchi need to be repaired,
which would allow further reduction in morbidity where
no clear benefit is to be gained. With this in mind
(and similar to other groups) we now only opt to extend a
slide only when absolutely necessary.
A limitation of our study is that the data are retrospective
and despite being 1 of the largest reports, it is still relatively
underpowered. Future studies will benefit from the data
being prospective (and multicenter), and we welcome the
formation an international registry for LSCTS. In our
unit, a prospective database has been established (3 years),
which will improve future reports. As the national referral
center for complex pediatric tracheal disease, we manage
almost all children in the United Kingdom with LSCTS,
and we are confident that our cohort is representative of
the range of patient characteristics found in LSCTS.
We acknowledge that our international referrals may alter
our case mix by increasing the proportion of children with
more complex disease, but this only accounts for a small
percentage of cases (11%) and has not influenced our
analysis. Our study reports the longest follow-up to date,
and it is very encouraging that most patients are in a stable
condition 1 year after initial surgery. We are currently
undertaking formal quality of life studies in our patient
cohort, but we are comfortable reporting our impression
that the vast majority of treated children are leading very
good and largely asymptomatic lives.
CONCLUSIONS
STP is an extremely versatile technique that can be
readily applied to the various airway configurations seen1788 The Journal of Thoracic and Cardiovascular Surin LSCTS. Our data reveal predictors of adverse outcomes
to be bronchial stenosis, preoperative ECMO, and
preoperative malacia. We avoid stenting unless absolutely
necessary, but when necessary bioabsorbable stents appear
to be effective. Centralization of care has allowed us to gain
considerable experience with this and other rare airway
conditions, and we advocate such a strategic approach.
We believe that a multidisciplinary team working with
aggressive postoperative care is key to improved outcomes,
and we consider STP to be the gold standard for LSCTS
treatment, resulting in comparatively lower morbidity and
mortality.
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Dr Carl L. Backer (Chicago, Ill). First, I would like to
acknowledge the efforts of Martin Elliott, who unfortunately
could not be here today. Martin spearheaded use of the slide
tracheoplasty and the emphasis on a multidisciplinary approach
to these complex patients.
Dr Speggiorin, your experience is with more than 100 patients,
50% of them arriving intubated, and 10% arriving requiring
extracorporeal membrane oxygenation. The mortality rate of
only 7% in the final 70 patients demonstrates the excellent
results that can be achieved with slide tracheoplasty and a focused
team.The Journal of Thoracic and CarOur own series of tracheal stenosis operations at Lurie
Children’s Hospital now numbers more than 80 patients, and we
have used the slide tracheoplasty technique in the past 18 patients.
Our strategy change to use slide tracheoplasty instead of
pericardial tracheoplasty and the autograft was largely based on
the excellent results reported by your center, the late Dr Hermes
Grillo, and Dr Peter Manning. Our experience shows that it is
possible for a center that was heavily invested in 1 operation—
the pericardial patch tracheoplasty was first performed at our
institution—to change to a new technique (the slide tracheoplasty)
based on the results of other surgeons.
It is interesting that you are using an interrupted suture
technique that we originally proposed. We have abandoned
interrupted sutures and changed to the running suture technique!
We have also not used the betadine irrigation system in our
80 patients and have a very low incidence of mediastinitis.
I am hoping Dr Manning will comment on these 2 points.
I have 3 questions for you.
The first question is in regard to the use of simple tracheal
resection and end-to-end anastomosis. When I first started my
career, everyone said it was safe to resect 50% of the trachea.
Then a group from Boston proposed that you should resect no
more than 30% of the trachea. I wonder if we should be using
a slide tracheoplasty for almost all of these tracheal stenoses,
even if it is a short segment of the trachea, say 10% to 20% of
the total length. Do you have any comments about that?
Dr Speggiorin. I agree with you. When you have a short
stenotic segment an end-to-end anastomosis is a good technique.
Slide tracheoplasty can be used with both long and short stenotic
segments. Theoretically, if you do a mini slide tracheoplasty
on a short segment, the risk of postscarring stenosis can be
minimized. It is the same principle that you can have when you
do a coarctation repair. I know that the structures are different,
but it is the same principle because the suture line is longer. Slide
tracheoplasty also means shorter segments should be adopted.
Dr Backer. Thank you. I have had the experience of thinking
I could do a tracheal resection and then suddenly realizing that
the segment I need to resect is a lot longer than I thought and really
wishing I would have just done a slide tracheoplasty.
My second question relates to 1 of the advantages to being in the
United Kingdom. You use the phrase ‘‘quaternary referral center.’’
It sounds like all of the patients in the United Kingdom with
tracheal stenosis are coming to your single center. I guess you
are probably going to agree with this, but the question is: Should
surgeons who are only doing 1 tracheoplasty every couple of years
be performing this operation or should they be referring patients to
specialized centers that have a multidisciplinary team approach
and extensive experience with this operation?
Dr Speggiorin. Following the principle that the more you do
the better you become, I support this. Managing patients with
very rare and complex disease can have a massive influence on
the outcome if there is 1 institution where all the specialized
care is centralized. Not only from the surgical point of view,
because we realize that surgery is only a small part of patient
care. The biggest part is what happens after surgery. This is shown
by the fact that half of our patients need additional intervention
after slide tracheoplasty. Having only 1 center within the entire
United Kingdom—I know that is not possible in the United Statesdiovascular Surgery c Volume 147, Number 6 1789
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Dbecause it is bigger—allows us follow-up with our patients in a
very manageable way. We know where they are and can build a
good relationship with the family. And the interventional
radiologists are getting better as well. The more you do, the better
you become, of course.
Dr Backer. My final question concerns the absorbable stent.
I do not believe that is available in the United States at this point.
We have had patients who have undergone slide tracheoplasty
and then still have problems with bronchomalacia, particularly
single-lung patients. Tell us about your experience with that stent.
It looks like it worked pretty well.
Dr Speggiorin. Yes, the stent is a PDS stent. They are
handcrafted in the Czech Republic. The initial experience was as
an esophageal stent and then they started to put it in adult
patients after lung transplant when they had a bronchial stenosis.
We adopted these stents in kids.
The experience is not very big because we are dealing with a
very rare situation, but we know that after a couple of months—
as it starts to dissolve—the stent starts to lose its radial force. It
does not dissolve in 1 go; it is a slow process that gives us time
to evaluate with serial bronchoscopy if the trachea becomes
stiffer or not. So far we have had no technical problems in
inserting these stents. The problem is that these stents are not on
the market. You need to measure the airways and custom order
a stent this length, this radial force, and this diameter. This is a
little bit tricky sometimes, but we are using this device more and
more.
Dr Peter Manning (St Louis, Mo). I have 2 comments and
questions. But first I want to point out that the results of this
experience are really remarkable. Some of the numbers from my
own experience are not exactly comparable, because these authors
report the kids with stenoses longer than 50%, and a lot of reports
include even shorter segment stenosis. You are to be congratulated
for your results in this very complex end of the spectrum.
One comment and question I have is about the incidence of
mechanical ventilation preoperatively. Half of the patients or
more were on mechanical ventilators. I think in your univariate
analysis that was predictive of mortality. Clearly, plastic tubes
are not a friend of small airways. I think we all realize that.
Most of these kids come to us intubated. But, frankly, most of these
kids are not too symptomatic until a few months of age when they
get that second hit—an upper respiratory infection—that trips
them up and they wind up intubated. Then we have secondary
damage. We give them inflammation and problems created by
forcing an endotracheal tube into a small airway.
I think some of this morbidity is modifiable. We undertook
an approach a number of years ago to try to get these kids
extubated preoperatively. When I look back over our results,
which did include all lengths of stenoses, 20% of the entire
series of about 130 patients went to the operating room
intubated. But when I look at just the least 50 patients, we
had it down to 9%. There were clearly a lot of factors leading
to this, but some of it was related to an aggressive approach,
of getting these kids extubated early to see if this is really a
modifiable risk factor.1790 The Journal of Thoracic and Cardiovascular SurHave you had any experience trying to get these patients
extubated, or off extracorporeal membrane oxygenation even,
preoperatively? And what percent of kids came to you intubated
and what percent ended up requiring intubation after arrival at
your institution?
Dr Speggiorin. In our univariate analysis the preoperative
ventilation was significant against death. When a patient is
admitted to our institution and is intubated and ventilated, that
patient is considered ‘‘urgent’’ and goes to the operating room
using a preferential pathway. We do not consider extubating
patients before surgery. Also, according to the multivariate
analysis preoperative ventilation is not significant.
Dr Backer. In our series we rarely if ever go into the bronchus
as part of our strategy for doing a slide tracheoplasty. One of the
frequent telephone calls that I get is from a surgeon who is going
to do a slide tracheoplasty saying that a radiologist has indicated
that the patient has severe left bronchial stenosis, and what do
I think about going into the bronchus? I almost always say that
usually there is not an associated bronchial stenosis and often
this is an overread by the computed tomography scan.
Now, in your series about 25% of patients had extension into the
bronchus. It also seemed like those are the patients who got
bronchomalacia and had problems with stents. So do you really
think that is the right strategy?
Why don’t you comment, and then Dr Manning can give us his
analysis on this issue.
Dr Speggiorin. The indication for extending into the bronchus
is whenever we find that there is a complete tracheal ring on the
bronchus. Sometimes it can be found during the preoperative
assessments and sometimes we find it once we are in the operative
theater. When we see there is a stenosis, we just go inside.
On top of this, sometimes we use the bronchus for the repair
because we extend the slide into the bronchus whenever we have
a difficult anatomy. For example, when the right upper lobar
bronchus takes off from the trachea. We use the slide to extend
the slide into the bronchus to allow us to have a good slide.
Dr Backer. Peter, what are your thoughts? Do you go into the
bronchus frequently?
Dr Manning. My experience mirrors yours, Carl, we haven’t.
And my question is related to the evaluation. Bronchial stenosis
is a difficult thing to evaluate. We did not have any experiencewith
this using OCTor bronchography, but evaluating it endoscopically
is difficult and dangerous. One probably should not be going down
to the bronchus in these kids preoperatively with a bronchoscope.
And computed tomography shows air in the airway. It cannot
differentiate between stenosis and compression or even a mucous
plug.
My question concerns these other diagnostic modalities, and did
they supply additional information that prompted the decision to
extend the repair into the bronchi? Extending into the bronchus
may be creating more problems than you are solving. I have almost
routinely limited the distal extent of the repair to the carina, even
when the bronchus may look a little bit small on a computed
tomography scan, and have not gotten into a lot of problems
with the bronchi postoperatively by doing that.gery c June 2014
